No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
ASX Market Update: Telcos Strong in Weak Market | 10 July 2024
Imugene Commences Patient Dosing in Phase 1 Bile Tract Cancer Trial; Shares Up 8%
2 ASX Shares Roaring Higher on Big News
Imugene Doses First Patient for VAXINIA Bile Tract Cancer Trial in Melbourne
Imugene Doses First Patient of Bile Tract Cancer in Phase One Clinical Trial; Shares Decline 6%
Is Imugene (ASX:IMU) In A Good Position To Deliver On Growth Plans?
No Data